The Sunday, January, 27th edition of the Arizona Daily Star had two significant articles, one above the fold on page one of the paper, about the SynCardia temporary Total Artificial Heart and one of SynCardia’s patients at UAMC, Justin Ryder.
SynCardia a heartbeat from leadership role –
In doing so, SynCardia Systems Inc. could become the next Ventana Medical Systems – a University of Arizona technology spinoff that was acquired by Swiss drug giant Roche for $3.4 billion and now employs more than 1,000 people in Oro Valley.
SynCardia’s temporary Total Artificial Heart received U.S. Food and Drug Administration approval for prospective transplant patients in 2004, and the device also has been approved in Canada and Europe. More than 1,100 have been implanted worldwide.
Read More at :
Artificial heart will keep on ticking until transplant –
Justin Ryder has battled heart problems nearly all his adult life.
But after multiple surgeries, the 35-year-old Las Vegas, Nev., resident finally has a ticker that works – SynCardia’s temporary Total Artificial Heart.
Running out of options with his patched-up natural heart, Ryder had an artificial one implanted in early December at the University of Arizona Medical Center. It keeps him going, literally, while he awaits a donor heart.
Read all of Justin’s story at: